Jason Litten's most recent trade in Genelux Corp was a trade of 275,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Genelux Corp | Jason Litten | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 275,000 | 275,000 | - | - | Stock Option (Right to Buy) |